ADUS vs. OPCH, AMED, BTSG, AHCO, AVAH, EHAB, LHCG, CHE, VKTX, and ITCI
Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Option Care Health (OPCH), Amedisys (AMED), BrightSpring Health Services (BTSG), AdaptHealth (AHCO), Aveanna Healthcare (AVAH), Enhabit (EHAB), LHC Group (LHCG), Chemed (CHE), Viking Therapeutics (VKTX), and Intra-Cellular Therapies (ITCI). These companies are all part of the "medical" sector.
Addus HomeCare (NASDAQ:ADUS) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, community ranking, dividends, profitability and media sentiment.
Addus HomeCare received 254 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 67.26% of users gave Addus HomeCare an outperform vote while only 58.97% of users gave Option Care Health an outperform vote.
Option Care Health has a net margin of 6.15% compared to Addus HomeCare's net margin of 6.04%. Option Care Health's return on equity of 18.92% beat Addus HomeCare's return on equity.
In the previous week, Addus HomeCare had 10 more articles in the media than Option Care Health. MarketBeat recorded 16 mentions for Addus HomeCare and 6 mentions for Option Care Health. Option Care Health's average media sentiment score of 0.95 beat Addus HomeCare's score of 0.54 indicating that Option Care Health is being referred to more favorably in the news media.
Addus HomeCare has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Option Care Health has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
Option Care Health has higher revenue and earnings than Addus HomeCare. Option Care Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.
95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 98.1% of Option Care Health shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by insiders. Comparatively, 0.6% of Option Care Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Addus HomeCare presently has a consensus price target of $110.43, indicating a potential downside of 3.82%. Option Care Health has a consensus price target of $40.00, indicating a potential upside of 34.14%. Given Option Care Health's stronger consensus rating and higher probable upside, analysts plainly believe Option Care Health is more favorable than Addus HomeCare.
Summary
Option Care Health beats Addus HomeCare on 10 of the 18 factors compared between the two stocks.
Get Addus HomeCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Addus HomeCare Competitors List
Related Companies and Tools
